1. New anticoagulants;Eikelboom;Circulation,2010
2. Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development;Ufer;Thromb Haemost,2010
3. Boehringer Ingelheim. Pradaxa prescribing information. http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf. Accessed November 9, 2012.
4. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009
5. Food and Drug Administration. FDA Drug Safety Communication: update on the risk for serious bleeding events with the anticoagulant Pradaxa (dabigatran). www.fda.gov/Drugs/DrugSafety/ucm326580.htm. Accessed November 9, 2012.